Skip to main content
. 2015 Mar 24;2(1):86–114. doi: 10.3934/publichealth.2015.1.86

Figure 2. T cell and cancer cell interactions and targets of immunomodulatory mAbs. Reproduced with permission from Sanlorenzo et al.

Figure 2.